LEADER 01215nam0 22002893i 450 
001 VAN0110077
005 20230615022434.675
017 70$2N$a978-1-4614-8809-5
100   $a20170629d2014       |0itac50      ba
101   $aeng
102   $aUS
105   $a||||    |||||
200 1 $aAdvances in Tumor Immunology and Immunotherapy$fedited by Joseph D. Rosenblatt ... [et al.]
210   $aNew York$cSpringer$d2014
215   $aix, 371 p.$d24 cm
410  1$1001VAN0110078$12001 $aCurrent Cancer Research$1210  $aNew York$cSpringer$d2017-
620   $aUS$dNew York$3VANL000011
702  1$aRosenblatt$bJoseph D.$3VANV085148
712   $aSpringer <editore>$3VANV108073$4650
801   $aIT$bSOL$c20240614$gRICA
856 4 $uhttps://link.springer.com/book/10.1007/978-1-4614-8809-5$zE-book ? Accesso al full-text attraverso riconoscimento IP di Ateneo, proxy e/o Shibboleth
899   $aBIBLIOTECA CENTRO DI SERVIZIO SBA$2VAN15
912   $fN
912   $aVAN0110077
950   $aBIBLIOTECA CENTRO DI SERVIZIO SBA$d15CONS      SBA EBOOK 1400                      $e15EB 1400              20170629            
996   $aAdvances in Tumor Immunology and Immunotherapy$91466227
997   $aUNICAMPANIA